Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 12/20 | 0.82 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.82 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.82 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.82 |
| ▸ | FGFR1 | P11362 | 5/20 | 0.77 |
| ▸ | STK10 | O94804 | 2/20 | 0.77 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.77 |
| ▸ | RET | P07949 | 2/20 | 0.77 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.77 |
| ▸ | DDR1 | Q08345 | 2/20 | 0.77 |
| ▸ | SLK | Q9H2G2 | 2/20 | 0.77 |
| ▸ | NUAK2 | Q9H093 | 1/20 | 0.77 |
| ▸ | KDR | P35968 | 16/20 | 0.72 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.72 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.72 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.72 |
| ▸ | ABL1 | P00519 | 1/20 | 0.72 |
| ▸ | EGFR | P00533 | 1/20 | 0.72 |
| ▸ | LCK | P06239 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23685375 | 0.93 | CYP3A4 (0.83) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 | |
| SCHEMBL23685279 | 0.93 | CYP3A4 (0.83) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 | |
| SCHEMBL14387702 | 0.90 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 | |
| SCHEMBL25450294 | 0.89 | CYP3A4 (0.76) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 | |
| SCHEMBL13412331 | 0.88 | CYP3A4 (0.91) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 | |
| SCHEMBL25450292 | 0.87 | CYP3A4 (0.83) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 | |
| Brivanib Alaninate SCHEMBL13108648 | 0.87 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 | |
| Brivanib Alaninate SCHEMBL483382 | 0.87 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 | |
| Brivanib Alaninate SCHEMBL18319845 | 0.87 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 | |
| Brivanib Alaninate SCHEMBL28365380 | 0.87 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230141981-A1 | NOVEL COMPOUNDS AND COMPOSITION FOR TARGETED THERAPY OF KIDNEY-ASSOCIATED CANCERS | Shanghai MICURX Pharmaceuticals Co., Ltd. (CN) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230141981-A1 | NOVEL COMPOUNDS AND COMPOSITION FOR TARGETED THERAPY OF KIDNEY-ASSOCIATED CANCERS | GLS, ATP6V1B1, KRAS | CYP3A4 4339/4885CYP2D6 3295/4885CYP2C9 4256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.